Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Feds’ case spotlights Shkreli’s disastrous biotech short — which forced him to launch Retrophin
Feds’ case spotlights Shkreli’s disastrous biotech short — which forced him to launch Retrophin
Feds’ case spotlights Shkreli’s disastrous biotech short — which forced him to launch Retrophin
Submitted by
admin
on July 7, 2017 - 10:36am
Source:
Endpoints
News Tags:
Martin Shkreli
biotech
Retrophin
fraud
Headline:
Feds’ case spotlights Shkreli’s disastrous biotech short — which forced him to launch Retrophin
Do Not Allow Advertisers to Use My Personal information
